Community-associated methicillin-resistant Staphylococcus aureus in outpatients, United States, 1999-2006. Emerg Infect Dis 15:1925-1930. PMCID: 3044510

Princeton University, Princeton, New Jersey, USA.
Emerging Infectious Diseases (Impact Factor: 6.75). 12/2009; 15(12):1925-30. DOI: 10.3201/eid1512.081341
Source: PubMed


Community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) has become a major problem in US hospitals already dealing with high levels of hospital-associated MRSA (HA-MRSA). Using antimicrobial drug susceptibility data for 1999-2006 from The Surveillance Network, we characterized the relationship between outpatient and inpatient levels of CA-MRSA nationally. In outpatients, the frequency of CA-MRSA isolates has increased >7 x during 1999-2006, which suggests that outpatients have become a major reservoir for CA-MRSA. However, contrary to results in other reports, although CA-MRSA increases are associated with decreases in the frequency of HA-MRSA in hospitals, the decreases are only modest. This finding suggests that instead of replacing HA-MRSA in the hospital, CA-MRSA is adding to the overall presence of MRSA already found within the hospital population.

Download full-text


Available from: Eili Y Klein, Mar 11, 2014
  • Source
    • "Methicillin-resistant S. aureus (MRSA), which have developed resistance to virtually all b-lactam antibiotics [4], are a major concern. MRSA are especially troublesome in hospitals, prisons, schools, and nursing homes where patients with open wounds, invasive devices, and/or weakened immune systems are at high risk of infection [5]. Although the bactericidal properties of some polymers were reported as early as in 1965 [6], antimicrobial polymers represent a class of increasingly important materials that may represent an alternative to current biocides and, in some cases, even to antibiotics . "
    [Show abstract] [Hide abstract]
    ABSTRACT: Biomaterial-associated infections represent a significant clinical problem, and treatment of these microbial infections is becoming troublesome due to the increasing number of antibiotic-resistant strains. Here, we report a naturally functionalized bacterial polyhydroxyalkanoate (PHACOS) with antibacterial properties. We demonstrate that PHACOS selectively and efficiently inhibits the growth of methicillin-resistant Staphylococcus aureus (MRSA) both in vitro and in vivo. This ability has been ascribed to the functionalized side chains containing thioester groups. Significantly less (3.2-fold) biofilm formation of S. aureus was detected on PHACOS compared to biofilms formed on control poly(3-hydroxyoctanoate-co-hydroxyhexanoate) and poly(ethylene terephthalate), but no differences were observed in bacterial adhesion among these polymers. PHACOS elicited minimal cytotoxic and inflammatory effects on murine macrophages and supported normal fibroblast adhesion. In vivo fluorescence imaging demonstrated minimal inflammation and excellent antibacterial activity for PHACOS compared to controls in an in vivo model of implant-associated infection. Additionally, reductions in neutrophils and macrophages in the vicinity of sterile PHACOS compared to sterile PHO implant were observed by immunohistochemistry. Moreover, a similar percentage of inflammatory cells was found in the tissue surrounding sterile PHACOS and S. aureus pre-colonized PHACOS implants, and these levels were significantly lower than S. aureus pre-colonized control polymers. These findings support a contact active surface mode of antibacterial action for PHACOS and establish this functionalized polyhydroxyalkanoate as an infection-resistant biomaterial.
    Biomaterials 10/2013; 35(1). DOI:10.1016/j.biomaterials.2013.09.059 · 8.56 Impact Factor
  • Source
    • "Necrotizing pneumonia largely occurred in young people with a median age of 22 years, only slightly higher than reported earlier in smaller series [1,3,7,13,17]. The increasing of age of included patients might be attibuable to a delayed exposure to the causative organism. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Necrotizing pneumonia attributed to Panton-Valentine leukocidin-positive Staphylococcus aureus has mainly been reported in otherwise healthy children and young adults, with a high mortality rate. Erythroderma, airway bleeding, and leukopenia have been shown to be predictive of mortality. The objectives of this study were to define the characteristics of patients with severe leukopenia at 48-h hospitalization and to update our data regarding mortality predicting factors in a larger population than we had previously described. It was designed as a case-case study nested in a cohort study. A total of 148 cases of community-acquired, necrotizing pneumonia were included. The following data were collected: basic demographic information, medical history, signs and symptoms, radiological findings and laboratory results during the first 48 h of hospitalization. The study population was divided into 2 groups: (1) with severe leukopenia (leukocyte count <=3,000 leukocytes/mL, n=62) and (2) without severe leukopenia (>3,000 leukocytes/mL, n=86). Median age was 22 years, and the male-to-female gender ratio was 1.5. The overall in-hospital mortality rate was 41.2%. Death occurred in 75.8% of severe leukopenia cases with median survival time of 4 days, and in 16.3% of cases with leukocyte count >3,000/mL (P<0.001). Multivariate analysis indicated that the factors associated with severe leukopenia were influenza-like illness (adjusted odds ratio (aOR) 4.45, 95% CI (95% confidence interval) 1.67-11.88, P=0.003), airway bleeding (aOR 4.53, 95% CI 1.85-11.13, P=0.001) and age over 30 years (aOR 2.69, 95% CI 1.08-6.68, P=0.033). A personal history of furuncles appeared to be protective (OR 0.11, 95% CI 0.01-0.96, P=0.046). S. aureus-necrotizing pneumonia is still an extremely severe disease in patients with severe leukopenia. Some factors could distinguish these patients, allowing better initial identification to initiate adapted, rapid administration of appropriate therapy.
    BMC Infectious Diseases 08/2013; 13(1):359. DOI:10.1186/1471-2334-13-359 · 2.61 Impact Factor
  • Source
    • "�io�lms have been shown to have survival and defense mechanisms that inhibit the healing aspects of in�ammatory cells, resist antibiotics (topical and systemic) and other therapies, and initiate cell-to-cell communication pathways (quorum sensing) which facilitate new bio�lm growth, resulting in recalcitrant nonhealing wounds [2]. With the increase of drug-resistant organisms such as methicillin-resistant Staphylococcus aureus (MRSA) [21], there is a need for innovative therapies in the treatment of Ulcers wound bio�lms. �ound larval debridement therapy (LDT) has been shown to have promise in healing chronic wounds by eradicating bio�lms. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Chronic wounds are a signi�cant health problem in the United States, with annual associated costs exceeding $20 billion annually. Traditional wound care consists of surgical debridement, manual irrigation, moisture retentive dressings, and topical and/or systemic antimicrobial therapy. However, despite progress in the science of wound healing, the prevalence and incidence of chronic wounds and their complications are escalating. e presence � complexity of bacterial bio�lms in chronic wounds has recently been recognized as a key aspect of non-healing wounds. �acterial bio�lms are sessile colonies of polymicrobial organisms (bacteria, fungus, etc.) enclosed within a self-produced exopolymeric matrix that provides high levels of tolerance to host defenses, antibiotics and antiseptics. us, there is a need for alternative therapies to reduce bio�lms in chronic wounds. In this report, we present initial �ndings from in vitro experiments which show that larval debridement therapy with disinfected blow �y larvae (Phaenicia sericata) reduced total CFUs (�-logs) of planktonic and mature bio�lms of Pseudomonas aeruginosa or Staphylococcus aureus grown on dermal pig skin explants by 5-logs a�er 24 hours of exposure, and eliminated bio�lms (no measurable CFUs) a�er 48 hours of exposure.
    02/2013; DOI:10.1155/2013/487024
Show more